BRCA1 and breast carcinoma: These results also provide more evidence to support recent findings that anti‐inflammatory treatment reduces the incidence of early metastatic relapse in breast cancer patients and decreases tumor growth in mice models for dormancy.[qv: 47,48] Interestingly, our result shows that Brca1 mutant‐associated tumor microenvironment is different from that of Trp53 mutant‐associated type.